World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
95
Citations
39259
World Ranking
9954
National Ranking
353

Overview

Pietro Invernizzi is affiliated with the University of Milano-Bicocca in Italy and has a strong presence in the field of Medicine, particularly focused on liver-related diseases and treatments. Their research spans several subfields including Hepatology, Epidemiology, Surgery, Pulmonary and Respiratory Medicine, and Oncology.

Their work has frequently appeared in prominent publication venues such as:

  • Journal of Hepatology
  • Digestive and Liver Disease
  • Liver International
  • Hepatology
  • Zenodo (CERN European Organization for Nuclear Research)

Invernizzi's main topics of study include:

  • Liver Diseases and Immunity
  • Liver Disease Diagnosis and Treatment
  • Pediatric Hepatobiliary Diseases and Treatments
  • Gallbladder and Bile Duct Disorders
  • Cholangiocarcinoma and Gallbladder Cancer Studies
  • Neuroendocrine Tumor Research Advances
  • Liver Disease and Transplantation

Some of Invernizzi's recent papers include:

  • "Cholangiocarcinoma 2020: the next horizon in mechanisms and management" (2020), published in Nature Reviews Gastroenterology & Hepatology
  • "Genomewide Association Study of Severe Covid-19 with Respiratory Failure" (2020), published in New England Journal of Medicine
  • "Genome-wide association study of non-alcoholic fatty liver and steatohepatitis in a histologically characterised cohort" (2020), published in Journal of Hepatology
  • "High rates of 30-day mortality in patients with cirrhosis and COVID-19" (2020), published in Journal of Hepatology
  • "Efficacy and Safety of Elafibranor in Primary Biliary Cholangitis" (2023), published in New England Journal of Medicine

Frequent collaborators in their research include:

  • Marco Carbone
  • Alessio Gerussi
  • Laura Cristoferi
  • Nora Cazzagon
  • Sara Massironi

Best Publications

  • EASL Clinical Practice Guidelines: management of cholestatic liver diseases

    Ulrich Beuers;Kirsten M. Boberg;Roger W. Chapman;Olivier Chazouillères

  • Genomewide Association Study of Severe Covid-19 with Respiratory Failure.

    David Ellinghaus;Frauke Degenhardt;Luis Bujanda;Maria Buti

  • Cholangiocarcinoma 2020: the next horizon in mechanisms and management

    Jesus M. Banales;Jesus M. Banales;Jesus M. Banales;Jose J. G. Marin;Jose J. G. Marin;Angela Lamarca;Angela Lamarca;Pedro M. Rodrigues

  • EASL Clinical Practice Guidelines: The diagnosis and management of patients with primary biliary cholangitis

    Gideon M. Hirschfield;Ulrich Beuers;Christophe Corpechot;Pietro Invernizzi

  • Expert consensus document: Cholangiocarcinoma: current knowledge and future perspectives consensus statement from the European Network for the Study of Cholangiocarcinoma (ENS-CCA)

    Jesus M. Banales;Vincenzo Cardinale;Guido Carpino;Marco Marzioni

  • A Placebo-Controlled Trial of Obeticholic Acid in Primary Biliary Cholangitis

    F. Nevens;P. Andreone;G. Mazzella;S. I. Strasser

  • Microbiota-driven gut vascular barrier disruption is a prerequisite for non-alcoholic steatohepatitis development.

    Juliette Mouries;Paola Brescia;Alessandra Silvestri;Ilaria Spadoni

  • Primary biliary cirrhosis in monozygotic and dizygotic twins: Genetics, epigenetics, and environment ☆

    Carlo F Selmi;Carlo F Selmi;Marlyn J. Mayo;Nancy Bach;Hiromi Ishibashi

  • Levels of alkaline phosphatase and bilirubin are surrogate end points of outcomes of patients with primary biliary cirrhosis: An international follow-up study

    Willem J. Lammers;Henk R. van Buuren;Gideon M. Hirschfield;Harry L.A. Janssen

  • Changing nomenclature for PBC: from ‘cirrhosis’ to ‘cholangitis’

    Ulrich H W Beuers;M Eric Gershwin;Robert G Gish;Pietro Luigi Invernizzi

  • Genome-wide meta-analyses identify three loci associated with primary biliary cirrhosis

    Xiangdong Liu;Pietro Invernizzi;Yue Lu;Roman Kosoy

  • Macrophage plasticity and polarization in liver homeostasis and pathology

    Antonio Sica;Pietro Invernizzi;Alberto Mantovani

  • Patient Age, Sex, and Inflammatory Bowel Disease Phenotype Associate With Course of Primary Sclerosing Cholangitis

    Tobias J. Weismüller;Tobias J. Weismüller;Palak J. Trivedi;Annika Bergquist;Mohamad Imam;Mohamad Imam

  • Development and Validation of a Scoring System to Predict Outcomes of Patients With Primary Biliary Cirrhosis Receiving Ursodeoxycholic Acid Therapy

    Willem J. Lammers;Gideon M. Hirschfield;Christophe Corpechot;Frederik Nevens

  • Dense genotyping of immune-related disease regions identifies nine new risk loci for primary sclerosing cholangitis

    Jimmy Z Liu;Johannes Roksund Hov;Trine Folseraas;Trine Folseraas;Eva Ellinghaus

  • The X chromosome and immune associated genes

    Ilaria Bianchi;Ana Lleo;M. Eric Gershwin;Pietro Invernizzi

  • High rates of 30-day mortality in patients with cirrhosis and COVID-19.

    Massimo Iavarone;Roberta D'Ambrosio;Alessandro Soria;Michela Triolo

  • Genome-wide association study of non-alcoholic fatty liver and steatohepatitis in a histologically-characterised cohort.

    Quentin M. Anstee;Quentin M. Anstee;Rebecca Darlay;Simon Cockell;Marica Meroni

  • Comparison of the clinical features and clinical course of antimitochondrial antibody‐positive and ‐negative primary biliary cirrhosis

    P Invernizzi;A Crosignani;P M Battezzati;G Covini

  • Dense genotyping of immune-related disease regions identifies nine new risk loci for primary sclerosing cholangitis

    Jimmy Z. Liu;Johannes Roksund Hov;Trine Folseraas;Eva Ellinghaus

Frequent Co-Authors

Carlo Selmi
Carlo Selmi Humanitas University
M. Eric Gershwin
M. Eric Gershwin University of California, Davis
Mauro Podda
Mauro Podda University of Cagliari
Ana Lleo
Ana Lleo Humanitas University
Gianfranco Alpini
Gianfranco Alpini Indiana University
Shannon Glaser
Shannon Glaser Texas A&M University
Gideon M. Hirschfield
Gideon M. Hirschfield University Health Network
Domenico Alvaro
Domenico Alvaro Sapienza University of Rome
Albert Parés
Albert Parés University of Barcelona
Aftab A. Ansari
Aftab A. Ansari University of California, Davis

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in medical careers in the USA, accelerated and flexible online programs can offer a fast track into healthcare professions. Many students look for efficient routes to enhance qualifications or pivot into niche areas, such as nursing leadership or psychiatric care. Options like a 1 year dnp program online allow experienced nurses to achieve a Doctor of Nursing Practice degree quickly, helping them advance into higher-level positions in under a year.

Prospective students may also consider enrolling in the 1 year dnp program online through schools that offer streamlined coursework and flexible schedules. For those starting their nursing journey, a 6 month lpn program online provides a rapid pathway to entering the workforce as a Licensed Practical Nurse.

Additionally, qualified nurses interested in mental health can pursue the fastest post master's pmhnp programs. These programs are designed for speed and flexibility, helping clinicians specialize in psychiatric mental health to meet growing demand.

Best Scientists Citing Pietro Invernizzi

Trending Scientists